Health Care & Life Sciences » Pharmaceuticals | Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. | Ownership

Companies that own Oramed Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Sabby Capital LLC
960,000
5.53%
170,000
2.34%
07/03/2018
Armistice Capital LLC
856,433
4.93%
856,433
0.32%
07/02/2018
Renaissance Technologies LLC
53,100
0.31%
-16,700
0%
06/30/2018
Barclays Bank Plc (Private Banking)
41,186
0.24%
0
0%
06/30/2018
BlackRock Fund Advisors
26,194
0.15%
26,194
0%
06/30/2018
Morgan Stanley & Co. LLC
24,743
0.14%
0
0%
06/30/2018
Migdal Mutual Funds Ltd.
24,181
0.14%
-2,713
0.01%
06/28/2018
PNC Bank, NA (Investment Management)
21,200
0.12%
0
0%
06/30/2018
Glenmede Investment Management LP
20,000
0.12%
0
0%
06/30/2018
DWS Investment GmbH
17,605
0.1%
-7,314
0%
06/30/2018

About Oramed Pharmaceuticals

View Profile
Address
Hi-Tech Park 2/4
Jerusalem JM 91390
Israel
Employees -
Website http://www.oramed.com
Updated 07/08/2019
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.